RSVAX | VMVIX | RSVAX / VMVIX | |
Total Expense Ratio | 1.30 | 0.19 | 684% |
Annual Report Gross Expense Ratio | 1.33 | 0.19 | 700% |
Fund Existence | 32 years | 19 years | - |
Gain YTD | 0.682 | 5.177 | 13% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 255M | 31B | 1% |
Annual Yield % from dividends | 0.37 | 2.10 | 18% |
Returns for 1 year | -5.62 | 7.67 | -73% |
Returns for 3 years | -3.08 | 17.46 | -18% |
Returns for 5 years | 22.76 | 65.08 | 35% |
Returns for 10 years | -23.21 | 87.80 | -26% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BGEFX | 14.54 | 0.12 | +0.81% |
Baillie Gifford International Growth 4 | |||
RNGHX | 69.57 | 0.05 | +0.07% |
American Funds New Economy R5E | |||
PYVSX | 17.04 | -0.05 | -0.29% |
Payden Equity Income SI | |||
SBRAX | 20.22 | -0.07 | -0.35% |
Segall Bryant & Hamill All Cap Ret | |||
IYSAX | 17.01 | -0.10 | -0.58% |
Macquarie Smid Cap Core Fund Class A |